See the DrugPatentWatch profile for Diprivan
Diprivan is used as an anesthetic agent [1]. Specifically, it is utilized for the induction and maintenance of anesthesia [1].
What is the active ingredient in Diprivan?
The active ingredient in Diprivan is propofol [1].
How does propofol work?
Propofol is a short-acting intravenous anesthetic agent. It is believed to exert its effects by potentiating the activity of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA-A receptor [1]. This potentiation leads to central nervous system depression [1].
What are the indications for Diprivan?
Diprivan is indicated for:
* Induction of anesthesia [1].
* Maintenance of anesthesia [1].
* Sedation for mechanically ventilated adult patients in the intensive care unit (ICU) [1].
* Sedation for diagnostic or minor surgical procedures [1].
When does the patent for Diprivan expire?
Information on the specific patent expiry dates for Diprivan is not provided in the given text. However, for comprehensive patent information on various drugs, resources like DrugPatentWatch.com can be consulted [2].
Can generic versions of Diprivan be made?
Once patents expire and regulatory hurdles are cleared, generic versions of medications, including those like Diprivan containing propofol, can be manufactured and marketed [2]. The availability of generic alternatives can impact pricing and market competition.